Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial reactive oxygen species (mROS) are primarily generated as byproducts of the electron transport chain (ETC) during oxidative phosphorylation, specifically at Complexes I and III (Murphy, 2009, Biochem J). Under physiological conditions, mROS serve as critical signaling molecules for cellular adaptation and homeostasis; however, an imbalance between ROS production and antioxidant defense leads to oxidative stress (Sies et al., 2017, Nat Rev Mol Cell Biol). This state causes cumulative damage to mitochondrial DNA, membrane lipids, and proteins, contributing to the progression of neurodegenerative diseases like Parkinson's and Alzheimer's, as well as cardiovascular disorders and aging (Dan Dunn et al., 2015, Rev Physiol Biochem Pharmacol). Pharmacological intervention typically focuses on mitochondria-targeted antioxidants, such as MitoQ or SkQ1, which accumulate in the mitochondrial matrix to neutralize superoxide and prevent lipid peroxidation (Smith & Murphy, 2010, Free Radic Biol Med). While promising, targeting this pathway is challenging because complete suppression of ROS can impair essential cellular functions like mitogen-activated protein kinase signaling and host defense, necessitating a narrow therapeutic window to maintain homeostatic signaling (Zorov et al., 2014, Physiol Rev).
Modulation of mitochondrial redox state through direct scavenging of superoxide and hydroxyl radicals, inhibition of specific electron transport chain complexes to reduce electron leakage, or activation of the Nrf2-mediated antioxidant response pathway.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial reactive oxygen species generation and oxidative stress pathway (mROS pathway).